Inovio Pharmaceuticals Inc
INO
Market Cap$125.95M
Close$
$1.96
27.7% downside
Current Fair Value
27.7% downsideOvervalued by 27.7% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $125.95 Million |
|---|---|
| Enterprise Value | $8.11 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-3.95 |
| Beta | 1.39 |
| Outstanding Shares | 38,830,053 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | 0 |
|---|---|
| PEG | 0 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 69356.07 |
| Enterprise Value to EBIT | -0.15 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0.99 |
| Debt to Equity | 280.84 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Inovio Pharmaceuticals Inc
CEO: Jong Kim